Loading…
Piramal Pharma (PPLPHARMA)₹246.37+0.07%Pharmaceuticals
At the end of the Sep 2026 quarter, Piramal Pharma's shareholders were: promoters 34.85%, FIIs 13.61%, DIIs 14.46%, public 36.68%, others 0.40%. Promoter holding is unchanged on the quarter. FII holding is down 16.62 percentage points from 30.23% a year earlier. 0.00% of promoter shares were pledged. It had 4,13,052 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 35.07% | 35.07% | 34.99% | 34.99% | 34.99% | 34.99% | 34.90% | 34.90% | 34.90% | 34.90% | 34.85% | 34.85% |
| FIIs | 32.47% | 30.54% | 31.37% | 31.69% | 31.64% | 31.45% | 30.82% | 30.23% | 29.62% | 30.13% | 12.47% | 13.61% |
| DIIs | 9.71% | 12.15% | 12.98% | 13.83% | 14.12% | 14.81% | 14.28% | 14.92% | 15.71% | 15.64% | 14.60% | 14.46% |
| Public | 22.37% | 21.87% | 20.19% | 19.04% | 18.85% | 18.41% | 19.44% | 19.44% | 19.33% | 18.99% | 37.60% | 36.68% |
| Others | 0.38% | 0.37% | 0.47% | 0.45% | 0.40% | 0.34% | 0.56% | 0.51% | 0.44% | 0.34% | 0.48% | 0.40% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 2,92,209 | 2,97,891 | 3,06,290 | 3,59,624 | 4,18,295 | 4,32,691 | 4,58,269 | 4,62,348 | 4,53,670 | 4,50,502 | 4,60,934 | 4,13,052 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| The Sri Krishna Trust (through its Trustee Mr. Ajay G Piramal and Dr. (Mrs.) Swati A. Piramal) | Promoter | 26.53% | 0.00 |
| Ca Alchemy Investments | Public | 17.87% | 0.00 |
| Hdfc Trustee Company Limited-Hdfc Flexi Cap Fund | DII | 5.62% | −2.02 |
| V3 Designs LLP | Promoter | 3.21% | 0.00 |
| PRL Realtors LLP | Promoter | 3.00% | 0.00 |
| East Bridge Capital Master Fund I Ltd | FII | 2.01% | 0.00 |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | DII | 1.57% | New |
| Indiahold Limited | Public | 1.31% | 0.00 |
| Piramal Welfare Trust | Promoter | 0.80% | 0.00 |
| Semplice Corporate Solutions Private Limited | Promoter | 0.66% | New |
| The Ajay G Piramal Foundation | Promoter | 0.33% | 0.00 |
| Mr. Anand Piramal | Promoter | 0.07% | 0.00 |
| Anand Piramal Trust | Promoter | 0.05% | 0.00 |
| Mr. Ajay G. Piramal | Promoter | 0.04% | 0.00 |
| Nandini Piramal Trust | Promoter | 0.04% | 0.00 |
| Mr. Peter DeYoung | Promoter | 0.03% | 0.00 |
| Ms. Nandini Ajay Piramal | Promoter | 0.02% | 0.00 |
| Master Dev Piramal DeYoung | Promoter | 0.01% | 0.00 |
| Ms. Anya Piramal DeYoung | Promoter | 0.01% | 0.00 |
| Semplice Corporate Solutions Private Limited (Formerly known as AASAN Corporate Solutions Private Limited) | Promoter | Exited | — |
Promoters held 34.85% of Piramal Pharma at the end of the Sep 2026 quarter, down 0.05 percentage points from 34.90% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 13.61% (up 1.14 percentage points from 12.47% a quarter earlier) and domestic institutions (DIIs) held 14.46% (down 0.14 percentage points from 14.60% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Piramal Pharma had 4,13,052 shareholders at the end of the Sep 2026 quarter, against 4,62,348 a year earlier.
Ca Alchemy Investments (Public) held 17.87% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.